Page last updated: 2024-08-21

dronabinol and Leukemia, Lymphocytic

dronabinol has been researched along with Leukemia, Lymphocytic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fisher, M; Grant, S; Lombard, C; Martin, BR; McKallip, RJ; Nagarkatti, M; Nagarkatti, PS; Ryu, S1

Other Studies

1 other study(ies) available for dronabinol and Leukemia, Lymphocytic

ArticleYear
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease.
    Blood, 2002, Jul-15, Volume: 100, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cannabinoids; Cell Survival; Dose-Response Relationship, Drug; Dronabinol; Drug Evaluation, Preclinical; Humans; Leukemia, Lymphoid; Ligands; Mice; Mice, Inbred C57BL; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Receptors, Cannabinoid; Receptors, Drug; Survival Rate; Treatment Outcome; Tumor Cells, Cultured

2002